Concepedia

Author

Robert K. McAtee

The University of Texas Health Science Center at San Antonio

Also Known As

R K McAtee, Robert K McAtee, Robert K. McAtee, Robert K. Mcatee, Robert McAtee

18

Publications

1.7K

Citations

14

H-Index

50

Concepts

All Affiliations

The University of Texas Health Science Center at San AntonioSouth Texas Veterans Health Care SystemMurphy Oil Corporation (United States)University Hospital of LausanneThe University of Texas at San Antonio
RK

About

Robert K. McAtee is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, antifungal agents, and drug resistance.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

406

2

Immunology

4

4

146

3

Health Sciences

3

3

281

4

Allergy

2

2

40

5

Public Health

1

1

17

Robert K. McAtee

×

16

Publications

1.7K

Citations

14

H-Index

YearCitations

Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in <i>Candida albicans</i> Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients

Sofía Perea, José L. López-Ribot, William R. Kirkpatrick,

Antimicrobial Agents and Chemotherapy

2001

466

Distinct Patterns of Gene Expression Associated with Development of Fluconazole Resistance in Serial <i>Candida albicans</i> Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis

José L. López-Ribot, Robert K. McAtee, Linda N. Lee,

Antimicrobial Agents and Chemotherapy

1998

207

Detection of <i>Candida dubliniensis</i> in Oropharyngeal Samples from Human Immunodeficiency Virus-Infected Patients in North America by Primary CHROMagar Candida Screening and Susceptibility Testing of Isolates

William R. Kirkpatrick, Sanjay G. Revankar, Robert K. McAtee,

Journal of Clinical Microbiology

1998

187

Epidemiology of Oropharyngeal<i>Candida</i>Colonization and Infection in Patients Receiving Radiation for Head and Neck Cancer

Spencer W. Redding, Richard C. Zellars, William R. Kirkpatrick,

Journal of Clinical Microbiology

1999

175

Interpretation of Trailing Endpoints in Antifungal Susceptibility Testing by the National Committee for Clinical Laboratory Standards Method

Sanjay G. Revankar, William R. Kirkpatrick, Robert K. McAtee,

Journal of Clinical Microbiology

1998

132

Multiple Resistant Phenotypes of <i>Candida albicans</i> Coexist during Episodes of Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients

José L. López-Ribot, Robert K. McAtee, Sofía Perea,

Antimicrobial Agents and Chemotherapy

1999

95

Efficacy of Voriconazole in a Guinea Pig Model of Disseminated Invasive Aspergillosis

William R. Kirkpatrick, Robert K. McAtee, Annette W. Fothergill,

Antimicrobial Agents and Chemotherapy

2000

79

A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance

Sanjay G. Revankar, William R. Kirkpatrick, Robert K. McAtee,

The American Journal of Medicine

1998

68

Clinical Evaluation and Microbiology of Oropharyngeal Infection Due to Fluconazole‐Resistant<i>Candida</i>in Human Immunodeficiency Virus–Infected Patients

Sanjay G. Revankar, Olga P. Dib, William R. Kirkpatrick,

Clinical Infectious Diseases

1998

66

Efficacy of SCH56592 in a Rabbit Model of Invasive Aspergillosis

William R. Kirkpatrick, Robert K. McAtee, Annette W. Fothergill,

Antimicrobial Agents and Chemotherapy

2000

64

Page 1